Brought to you by:
-
SVS points to 2023 achievements, challenges in coming year
The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December, Executive Director, Kenneth M. Slaw, PhD, underscored the organization’s growth, collaborative endeavors and key milestones attained in 2023. “Our members’ dedication and collaborative efforts across various councils, committees and departments have…
-
Could metformin be first-ever medical treatment that is effective at managing aneurysm disease?
There is a global interest in assessing whether metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is taken by millions of people every day for type-2 diabetes, has an effect on the progression of abdominal aortic aneurysms (AAAs). The LIMIT trial, a prospective randomized, level one, placebo-controlled, blinded…
-
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI), Journal of Vascular and Interventional Radiology (JVIR), and Journal of Vascular Surgery-Vascular Insights. The roundtable focused on the current challenges in diagnosing and treating lower…
-
VAM travel scholarships open doors for underrepresented medical students
The Society for Vascular Surgery (SVS) Resident and Student Outreach Committee (RSOC) is accepting applications through Jan. 8, 2024, for the Diversity Medical Student Travel Scholarship. The award aims to provide aspiring vascular surgeons from underrepresented racial and ethnic minorities with the opportunity to attend the 2024 Vascular Annual Meeting (VAM) in Chicago. Scholarship recipients…
-
Corner Stitch: On the vascular trainee opportunities on the conference calendar
Christopher Audu, MD, surveys the 2024 meeting landscape, highlighting prime opportunities for trainees to showcase their research. It is abstract submission, and this month I wanted to highlight a few national meetings that are “trainee friendly” for getting your work presented as a podium talk or poster presentation. This list is not exhaustive but hopefully…
-
Yao family and SVS Foundation establish James S.T. Yao Resident Research Award
In a tribute to the late James S.T. Yao, MD, PhD, a luminary in the field of vascular surgery, the Yao family and the SVS Foundation announced the renaming of the Resident Research Award to the James S.T. Yao Resident Research Award. The renaming of the award serves as a testament to Yao’s unwavering commitment…
-
JVS-VL to be open access beginning in January
The Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) will move from a subscription model to one of open access—freely available online—on Jan. 1, 2024. JVS-VL is the journal for both the SVS and the American Venous Forum (AVF) and is celebrating its 10th year of publication. The change is part of the larger…
-
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the popularity of the team approach spreads, according to a leading voice in the treatment of peripheral arterial disease (PAD). “I think the key is making sure we get to the patients…
-
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to overestimate the degree of narrowing’
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken by the Centers for Medicare & Medicaid Services (CMS). Two heavyweights in the stroke arena went head-to-head, sparring over whether the decision should have been taken at all. Two luminaries in…
-
baroreflex activation therapy, Barostim, carotid bulb, CVRx, Eastern Vascular Society, EVS 2023, vascular assist
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation therapy devices identified
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular surgeons in the arena of the carotid bulb— and drawing attention to a need for “clear and well-defined guidelines.” Discussion was stirred after the delivery of a case experience from the…